Get In Touch
Xeraya Capital Sdn Bhd
26.03–26.08, G Tower
#199 Jalan Tun Razak, KL
+603 2381 8700
Submit a Proposal

Iconic Therapeutics

Treatments for retinal disease and cancer

Iconic Therapeutics is a clinical-stage biopharmaceutical company dedicated to translating scientific insight into breakthrough medicines. Iconic has a deep understanding of the role of tissue factor (TF) in angiogenesis, inflammation, and metastasis which has led it to develop a new approach to retinal disease and cancer. Their lead product candidate, ICON-1, is a novel immune-conjugate fusion protein. ICON-1 works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of leading causes of blindness.

  • Founded


  • Partnered


View Website
Let's talk

Are you the next big thing?

We’re a team of VC/PE who are excited about innovative ideas in life sciences. Submit your proposal to us!